Viking Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Viking Therapeutics (VKTX) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Viking Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Viking Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Viking Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $37M | 1.4M | 26.28 |
| 2025-06-30 | $25M | 952k | 26.50 |
| 2025-03-31 | $14M | 597k | 24.15 |
| 2024-12-31 | $25M | 618k | 40.24 |
| 2024-09-30 | $21M | 329k | 63.31 |
| 2024-06-30 | $21M | 386k | 53.01 |
| 2024-03-31 | $23M | 274k | 82.00 |
| 2023-12-31 | $6.3M | 340k | 18.61 |
| 2023-09-30 | $1.6M | 144k | 11.07 |
| 2023-06-30 | $2.5M | 157k | 16.21 |
| 2023-03-31 | $3.1M | 187k | 16.65 |
| 2022-12-31 | $433k | 46k | 9.40 |
| 2022-09-30 | $112k | 41k | 2.73 |
| 2022-06-30 | $115k | 42k | 2.72 |
| 2022-03-31 | $231k | 76k | 3.03 |
| 2021-12-31 | $1.5M | 332k | 4.60 |
| 2021-09-30 | $1.7M | 271k | 6.28 |
| 2021-06-30 | $1.0M | 168k | 5.99 |
| 2021-03-31 | $1.9M | 306k | 6.32 |
| 2020-12-31 | $479k | 85k | 5.64 |
| 2020-09-30 | $2.0M | 337k | 5.82 |
| 2020-06-30 | $2.4M | 331k | 7.21 |
| 2020-03-31 | $1.8M | 391k | 4.68 |
| 2019-12-31 | $3.3M | 410k | 8.01 |
| 2019-09-30 | $4.0M | 580k | 6.88 |
| 2019-06-30 | $4.7M | 564k | 8.30 |
| 2019-03-31 | $2.7M | 272k | 9.94 |
| 2018-12-31 | $3.9M | 509k | 7.65 |
| 2018-09-30 | $3.6M | 206k | 17.42 |
| 2018-06-30 | $781k | 82k | 9.50 |
| 2018-03-31 | $278k | 63k | 4.39 |
| 2017-12-31 | $41k | 10k | 4.10 |
| 2017-03-31 | $7.0k | 4.5k | 1.55 |
| 2016-06-30 | $4.0k | 3.3k | 1.23 |
| 2016-03-31 | $4.0k | 2.5k | 1.61 |
| 2015-09-30 | $8.0k | 1.4k | 5.68 |